Drug points: Ocular damage associated with proton pump inhibitors

British Medical Journal

Volumn 314, Issue 7097, 1997, Pages 1805-

  Schonhofer P S ^a   Werner, B ^a   Troger U ^b  

^a Institute of Clinical Pharmacology   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; ANTIULCER AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CELL PH; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DRUG MEGADOSE; ENZYME ACTIVITY; EYE DISEASE; FEMALE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETINA ARTERY; STOMACH MUCOSA; STOMACH ULCER; THORAX PAIN; VASOCONSTRICTION; VISUAL IMPAIRMENT; CASE REPORT; CHEMICALLY INDUCED DISORDER; ISCHEMIC OPTIC NEUROPATHY; MIDDLE AGED; PAPILLEDEMA; VISUAL DISORDER;

ANTI-ULCER AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; OPTIC NEUROPATHY, ISCHEMIC; PAPILLEDEMA; VISION DISORDERS;

EID: 0031582415     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7097.1805     Document Type: Article

References (5)

1. Rodriguez LAG, Mannio S, Waliander MA. Ocular safety of antiulcer drugs. Lancet 1995;345:1059-66.
2. Anonymous. Irreversibler Gesichtsfeldausfall nach Protonenpumpenhemmer Pantoprazol (RIFUN). Arzne-integramm 1995;7:79-80.
3. Assouad M, Vicks SL, Pockroy MV, Willcourt RJ. Recurrent acute interstitial nephritis on rechallenge with omeprazole. Lancet 1994;344:549.
4. +-ATPase in vascular smooth muscle cells. Am J Physiol 1992;262:H1955-8.
5. Aalkjer C, Mulvany MJ. Effects of changes of intracellular pH on the contractility of rat resistance vessels. Progr Biochem Pharmacol 1998;23:150-5.